Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Innodata | INOD | Jan 24, 2025 | 40.28 | +1.51 |
Innospec | IOSP | Jan 24, 2025 | 114.43 | -0.88 |
InnovAge | INNV | Jan 24, 2025 | 3.73 | +0.81 |
Innovate | VATE | Jan 24, 2025 | 10.59 | +4.96 |
Innovation Beverage Group | IBG | Jan 24, 2025 | 0.83 | -7.59 |
Innovative Eyewear | LUCY | Jan 24, 2025 | 5.85 | -1.52 |
Innovative Industrial Properties | IIPR | Jan 24, 2025 | 67.97 | +1.01 |
Innovative Industrial Properties A Pref | IIPR-A | Jan 24, 2025 | 25.87 | +0.92 |
Innovative Solutions and Support | ISSC | Jan 24, 2025 | 11.14 | -0.89 |
Innovex International | INVX | Jan 24, 2025 | 16.81 | -0.24 |
Innovid | CTV | Jan 24, 2025 | 3.10 | +0.32 |
Innoviva | INVA | Jan 24, 2025 | 18.70 | +0.70 |
Innoviz Technologies | INVZ | Jan 24, 2025 | 1.83 | +2.23 |
InnSuites Hospitality | IHT | Jan 24, 2025 | 2.55 | -0.77 |
Innventure | INV | Jan 24, 2025 | 12.43 | +0.40 |
Inogen | INGN | Jan 24, 2025 | 11.44 | +3.25 |
Inotiv | NOTV | Jan 24, 2025 | 4.20 | -6.46 |
Inovio Pharmaceuticals | INO | Jan 24, 2025 | 2.18 | -4.80 |
Inozyme Pharma | INZY | Jan 24, 2025 | 1.41 | +6.82 |
InPoint Commercial Real Estate Pref A | ICR-A | Jan 24, 2025 | 19.98 | -0.17 |
Inseego | INSG | Jan 24, 2025 | 12.28 | -0.89 |
Insight Enterprises | NSIT | Jan 24, 2025 | 173.80 | -0.19 |
Insight Select Income Fund | INSI | Jan 24, 2025 | 16.62 | -1.19 |
Insmed | INSM | Jan 24, 2025 | 78.48 | +0.82 |
Insperity | NSP | Jan 24, 2025 | 78.34 | -1.10 |
Inspira Technologies Oxy B.H.N. | IINN | Jan 24, 2025 | 1.00 | -1.96 |
Inspirato A | ISPO | Jan 24, 2025 | 5.46 | -0.73 |
Inspire Medical Systems | INSP | Jan 24, 2025 | 188.47 | +0.47 |
Inspire Tactical Balanced ESG ETF | RISN | Jan 24, 2025 | 27.17 | -0.43 |
Inspire Veterinary Partners | IVP | Jan 24, 2025 | 0.12 | -6.14 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.